Wednesday, Dec 16 2020 | Time 20:38 Hrs(IST)
image
  • JEE (mains) to be held four times in year, in 13 languages: Pokhriyal
  • Vijay Diwas observed, 101 Area Shillong, ‘First in Dacca’
  • Section 144 enforced in Aurangabad till Dec 31
  • 106 candidates appointed on regular basis in Health Deptt
  • Olympian seeks PM intervention to save BFI
  • Bitcoin hits all-time high above $20,430
  • ICJS expansion with more integrated databases is satisfactory: Ajay Bhalla
  • Deepak Prakash seeks CM's resignation over failing to provide jobs to youth
  • Sixty IRS officers pass out from NACIN Faridabad
  • Recovery rate improves to 92 pc
  • Manoj Singh Rawat of ITBP becomes first ADG from the Force
  • SP'S Lawyer Wing protests demanding release of arrested party workers
  • BBSB int'l foundation honours special PS to CM
  • Moscow on sanctions against Akhmat: UEFA, FIFA must take US down peg in Football affairs
  • Five killed in road accident in Gopalganj
WorldPosted at: Dec 16 2020 5:44PM


China’s Fosun Pharma to bring BioNTech’s COVID-19 vaccine to domestic market: Statement

MOSCOW, Dec 16 (Sputnik) The Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has reached an agreement with Germany's BioNTech to introduce its signature mRNA-based COVID-19 vaccine to the Chinese market, the Chinese pharmaceutical company said on Wednesday.
"BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. today announced an agreement to supply Mainland China with 100 million doses initially of their BNT162 mRNA-based vaccine candidate against COVID-19 in 2021, subject to regulatory approval. Initial supply will be delivered from BioNTech’s production facilities in Germany," the Shanghai-based company said in a statement on its official website.
BioNTech’s BNT162 mRNA-based vaccine has already received regulatory approval in the United Kingdom, the United States and Canada.
Following Fosun Pharma’s announcement, its shares rose by 3.7 percent on Wednesday.
A number of COVID-19 vaccine candidates developed by Chinese pharmaceutical companies including Sinopharm and Sinovac are also pending official regulatory approval from Chinese authorities.

SPUTNIK ASN 1743
Tags: #China’s Fosun Pharma to bring BioNTech’s COVID-19 vaccine to domestic market: Statement
More News

Taliban team reaches Pakistan for talks

16 Dec 2020 | 8:18 PM

Islamabad, Dec 16(UNI) A Taliban delegation led by Mullah Abdul Ghani Baradar, arrived in Pakistan for a three-day visit on Wednesday.

see more..
Japan's Shionogi company announces launch of clinical trials of COVID-19 vaccine

Japan's Shionogi company announces launch of clinical trials of COVID-19 vaccine

16 Dec 2020 | 7:33 PM

Tokyo, Dec 16 (UNI) Japan's pharmaceutical company Shionogi (Shionogi & Co) on Wednesday announced the launch of clinical trials of its prophylactic vaccine candidate against COVID-19.

see more..
B'desh PM to meet Modi virtually

B'desh PM to meet Modi virtually

16 Dec 2020 | 7:04 PM

Dhaka, Dec 16 ( UNI) Bangladesh Prime Minister Sheikh Hasina will hold a virtual meeting with Indian Prime Minister Narendra Modi on Thursday, over the Novel Coronavirus situation.

see more..
COVID: Bangladesh reports 1,632 new cases, 27 deaths

COVID: Bangladesh reports 1,632 new cases, 27 deaths

16 Dec 2020 | 5:38 PM

Dhaka, Dec 16 (UNI) With the detection of 1,632 new COVID-19 cases, the total tally of the country surged to 4,95,841.

see more..
US claims Russia conducted anti-satellite missile test

US claims Russia conducted anti-satellite missile test

16 Dec 2020 | 5:34 PM

Washington, Dec 16 (UNI) The United States on Wednesday claimed that Russia has conducted an anti-satellite missile test.

see more..
image